Glenmede Trust Co. NA Buys 25 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Glenmede Trust Co. NA increased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,155 shares of the medical instruments supplier’s stock after acquiring an additional 25 shares during the quarter. Glenmede Trust Co. NA’s holdings in Mettler-Toledo International were worth $1,732,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Family Firm Inc. purchased a new position in shares of Mettler-Toledo International during the second quarter valued at about $25,000. Blue Trust Inc. boosted its stake in Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 17 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International during the 3rd quarter valued at approximately $37,000. Rothschild Investment LLC bought a new stake in Mettler-Toledo International in the 2nd quarter worth approximately $42,000. Finally, Itau Unibanco Holding S.A. purchased a new stake in shares of Mettler-Toledo International during the 2nd quarter worth approximately $42,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.94% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. JPMorgan Chase & Co. upped their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Wells Fargo & Company dropped their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Finally, Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $1,338.75.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,251.20 on Monday. The firm has a market capitalization of $26.40 billion, a PE ratio of 33.73, a price-to-earnings-growth ratio of 4.13 and a beta of 1.16. The business has a 50 day simple moving average of $1,345.17 and a two-hundred day simple moving average of $1,392.37. Mettler-Toledo International Inc. has a 1 year low of $1,068.33 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Equities research analysts expect that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.